Detalhe da pesquisa
1.
Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
Clin Exp Allergy
; 53(11): 1187-1197, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794659
2.
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.
J Pediatr
; 250: 45-53.e3, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948192
3.
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer.
Curr Oncol
; 31(3): 1633-1644, 2024 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534957
4.
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Curr Oncol
; 31(4): 1876-1898, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668044
5.
Asthmatic subjects with allergy have elevated levels of IgE+ B cells in the airways.
J Allergy Clin Immunol
; 140(2): 590-593.e9, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213181
6.
Factors associated with intention for revaccination among patients with adverse events following immunization.
Vaccine
; 41(42): 6239-6247, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666696
7.
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Curr Oncol
; 30(4): 3776-3786, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185399
8.
Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned.
Curr Oncol
; 29(8): 5616-5626, 2022 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005181
9.
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's RWE Data Working Group.
Curr Oncol
; 29(3): 2046-2063, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323365
10.
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel.
ERJ Open Res
; 8(1)2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295233
11.
Parenchyma-to-hydronephrosis Area Ratio Is a Promising Outcome Measure to Quantify Upper Tract Changes in Infants With High-grade Prenatal Hydronephrosis.
Urology
; 104: 166-171, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111223